Disclosure Of Fair Value Measurement [Text Block]

ABIONYX Pharma - Filing #2813091

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
15 823 EUR
21 832 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
7 169 EUR
2 726 EUR
192,000 EUR
8 599 EUR
229,000 EUR
1 418 EUR
126,000 EUR
201,000 EUR
169 829 EUR
10 677 EUR
10,000 EUR
179 214 EUR
87,000 EUR
1 396 EUR
5,000 EUR
39,000 EUR
1 232 EUR
6 629 EUR
164 822 EUR
170 322 EUR
136,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.